Home › Type 2 Diabetes › Texas › Austin
Pag-aaral pangklinika para sa Type 2 Diabetes sa Austin, TX
14 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Austin (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Nagre-recruit
- Texas Diabetes and Endocrinology, Austin
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Nagre-recruitPhase 3
- Texas Diabetes and Endocrinology - Central Austin, Austin
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Pinnacle Clinical Research - Austin, Austin
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Nagre-recruitPhase 3
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- IMA Clinical Research Austin, Austin
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Nagre-recruitPhase 2
- Elligo Health Research, Inc., Austin
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Nagre-recruitPhase 2
- IMA Clinical Research, Austin
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Nagre-recruitPhase 2
- Velocity Clinical Research, Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Nagre-recruitPhase 3
- Elligo Clinical Research Center, Austin
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Nagre-recruitPhase 3
- Texas Diabetes & Endocrinology, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Austin
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Nagre-recruitPhase 3
- Pinnacle Clinical Research, Austin
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
Nagre-recruit
- Texas Diabetes & Endocrinology, Austin
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Nagre-recruit
- Texas Diabetes and Endocrinology, Austin
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL25 pag-aaral
- Atlanta, GA21 pag-aaral
- San Diego, CA21 pag-aaral
- Boston, MA20 pag-aaral
- Miami, FL20 pag-aaral
- Chicago, IL19 pag-aaral
- Arlington, VA19 pag-aaral
- Los Angeles, CA18 pag-aaral
- Dallas, TX18 pag-aaral
- Columbus, OH17 pag-aaral
Iba pang pag-aaral sa Austin
- Non-Small Cell Lung Cancer29 pag-aaral
- Kanser (lahat ng uri)22 pag-aaral
- Obesity22 pag-aaral
- Overweight19 pag-aaral
- Metastatic Cancer18 pag-aaral
- Colorectal Cancer17 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Pagkabigo ng Puso17 pag-aaral
- Kanser ng Endometrium15 pag-aaral
- Kanser sa Suso15 pag-aaral
- Kanser sa Prostate14 pag-aaral
- Steatotic Liver Disease13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.